Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.710
-0.060 (-3.39%)
At close: Feb 21, 2025, 4:00 PM
1.670
-0.040 (-2.34%)
After-hours: Feb 21, 2025, 7:53 PM EST

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $32.24 million. The enterprise value is $13.21 million.

Market Cap 32.24M
Enterprise Value 13.21M

Important Dates

The next estimated earnings date is Thursday, March 6, 2025, before market open.

Earnings Date Mar 6, 2025
Ex-Dividend Date n/a

Share Statistics

CMMB has 18.86 million shares outstanding. The number of shares has increased by 30.61% in one year.

Current Share Class n/a
Shares Outstanding 18.86M
Shares Change (YoY) +30.61%
Shares Change (QoQ) +22.57%
Owned by Insiders (%) 15.80%
Owned by Institutions (%) 6.50%
Float 11.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.98
P/TBV Ratio 1.98
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.02.

Current Ratio 4.57
Quick Ratio 4.56
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -83.81% and return on invested capital (ROIC) is -55.20%.

Return on Equity (ROE) -83.81%
Return on Assets (ROA) -43.37%
Return on Invested Capital (ROIC) -55.20%
Return on Capital Employed (ROCE) -92.91%
Revenue Per Employee n/a
Profits Per Employee -$719,950
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +155.22% in the last 52 weeks. The beta is 0.46, so CMMB's price volatility has been lower than the market average.

Beta (5Y) 0.46
52-Week Price Change +155.22%
50-Day Moving Average 1.95
200-Day Moving Average 1.48
Relative Strength Index (RSI) 32.88
Average Volume (20 Days) 835,343

Short Selling Information

Short Interest 74,859
Short Previous Month 75,165
Short % of Shares Out 0.40%
Short % of Float n/a
Short Ratio (days to cover) 0.77

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -15.37M
Pretax Income -19.36M
Net Income -14.40M
EBITDA -15.31M
EBIT -15.37M
Earnings Per Share (EPS) -$0.97
Full Income Statement

Balance Sheet

The company has $19.38 million in cash and $342,000 in debt, giving a net cash position of $19.04 million or $1.01 per share.

Cash & Cash Equivalents 19.38M
Total Debt 342,000
Net Cash 19.04M
Net Cash Per Share $1.01
Equity (Book Value) 16.32M
Book Value Per Share 0.87
Working Capital 15.54M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -30.61%
Shareholder Yield -30.61%
Earnings Yield -44.66%
FCF Yield n/a

Analyst Forecast

The average price target for CMMB is $9.00, which is 426.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.00
Price Target Difference 426.32%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -58.72%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1